PRA Health Sciences’ Early Development Services (EDS) team of dedicated experts understands that obtaining patient safety and efficacy data early in the clinical pharmacology program plays a critical role in decision-making and lays the groundwork for efficient future development planning.
Early Phase Solutions
We understand the need to maximize success while minimizing time and costs. That’s why we strategically positioned our laboratories within close…
Human Abuse Potential and Liability (HAP)
We’ve successfully completed more Human Abuse Potential and Liability (HAP/HAL) protocols & published more HAP studies than any other CRO.
Chemical, Manufacturing, and Control Services (CMC)
Early drug development requires manufacturing of Investigational Medicinal Products (IMP) that comply with Good Manufacturing Practice (GMP) systems…